SANGAMO THERAPEUTICS, INC. Cash Equivalents, at Carrying Value
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Cash Equivalents, at Carrying Value of $41.92 million as of 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2025-03-17
- 2024-12-31: Cash Equivalents, at Carrying Value $41.92M.
- 2023-12-31: Cash Equivalents, at Carrying Value $45.20M.
- 2022-12-31: Cash Equivalents, at Carrying Value $100.44M.
- 2021-12-31: Cash Equivalents, at Carrying Value $178.87M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2024-12-31 | $41.92M 10-K · filed 2025-03-17 |
| 2023-12-31 | $45.20M 10-K · filed 2025-03-17 |
| 2022-12-31 | $100.44M 10-K · filed 2024-03-13 |
| 2021-12-31 | $178.87M 10-K · filed 2024-03-13 |
| 2020-12-31 | $131.33M 10-K · filed 2023-02-23 |
| 2019-12-31 | $80.43M 10-K · filed 2022-02-24 |
| 2018-12-31 | $140.42M 10-K · filed 2021-02-24 |
| 2017-12-31 | $49.83M 10-K · filed 2020-02-28 |